# The Role of Immune Semaphorins in NAFLD

> **NCT04573543** · — · COMPLETED · sponsor: **University Hospital for Infectious Diseases, Croatia** · enrollment: 160 (actual)

## Conditions studied

- Non-Alcoholic Fatty Liver Disease
- Immune Response
- Biomarkers
- Liver Fibrosis
- Non Alcoholic Steatohepatitis

## Interventions

- **DIAGNOSTIC_TEST:** Evaluation of the degree of fibrosis and steatosis
- **DIAGNOSTIC_TEST:** Screening for the components of metabolic syndrome
- **DIAGNOSTIC_TEST:** Measurement of serum semaphorin concentrations
- **DIAGNOSTIC_TEST:** Identification of semaphorin gene polymorphisms

## Key facts

- **NCT ID:** NCT04573543
- **Lead sponsor:** University Hospital for Infectious Diseases, Croatia
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-09-01
- **Primary completion:** 2021-09-01
- **Final completion:** 2022-03-01
- **Target enrollment:** 160 (ACTUAL)
- **Last updated:** 2023-08-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04573543

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04573543, "The Role of Immune Semaphorins in NAFLD". Retrieved via AI Analytics 2026-07-06 from https://api.ai-analytics.org/clinical/NCT04573543. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*